Successful downstaging of locally recurrent penile squamous cell carcinoma with neoadjuvant nanosomal docetaxel lipid suspension (NDLS) based regimen followed by curative surgery

• Published in: BMJ case reports 2017-11, Vol.2017, p.bcr-2017-220686
• Main Authors: Gupta, Sameer, Pawar, Shashi Singh, Bunger, Deepak
• Format: Article
• Language: English
• Subjects: Asia; Biopsy; Breast cancer; Cancer therapies; Case reports; Chemotherapy; Diabetes; Dissection; Genital cancers; Head & neck cancer; Indian Sub-Continent; Lipids; Lymphatic system; Male; Metastasis; Novel Treatment (New Drug/Intervention; Established Drug/Procedure in New Situation); Pain; Patients; Penis; Response rates; Squamous cell carcinoma; Surgery; Urological cancer
• ISSN: 1757-790X; 1757-790X
• DOI: 10.1136/bcr-2017-220686

Penile squamous cell carcinoma (pSCC) is a relatively rare disease in Western world but is a significant health problem in developing countries like India. We report here a case of successful multimodality management of recurrent pSCC with pelvic lymphadenopathy in a 56-year-old male patient with poorly controlled diabetes. The patient presented with ulceroproliferative growth over the residual penile stump clinically involving root of penis and with right pelvic lymphadenopathy. The patient had a history of partial penectomy done elsewhere 20 months ago. In view of the comorbidities, locally recurrent disease and presence of right Iliac lymphadenopathy, the patient was treated with nanosomal docetaxel lipid suspension (NDLS), cisplatin and 5-fluorouracil (TPF regimen) in the neoadjuvant setting followed by staged surgical resection. This is the first case report showing successful treatment of recurrent pSCC with NDLS-based TPF regimen in the neoadjuvant setting followed by staged surgery in a patient with poorly controlled diabetes.